about
ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infectionUSP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.Historical epidemiology of hepatitis C virus (HCV) in selected countries.Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.Strategies to manage hepatitis C virus (HCV) disease burden.Urgent liver transplantation for chemotherapy-induced HBV reactivation: a suitable option in patients recently treated for malignant lymphoma.Further evidence of the benefits associated with antiviral treatment in kidney allograft recipients with chronic hepatitis B virus infection.Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.N-acetyl cysteine averted liver transplantation in a patient with liver failure caused by erythropoietic protoporphyria.Fat mass and obesity-associated (fto) gene and alcohol intake.Genetic variation in TNFA predicts protection from severe bacterial infections in patients with end-stage liver disease awaiting liver transplantation.Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Liver transplantation in Eastern EuropeRevised King's College score for liver transplantation in adult patients with Wilson's diseaseThe effect of severe hepatic impairment on the pharmacokinetics and haematological response of C.E.R.A.Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha 2aHepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age
P50
Q33626857-9F8D0BF8-246A-4AB2-9935-E3C53A24191DQ35594196-30305F18-5B20-4BAE-A89D-6578EF8C7E5DQ36395264-E976A539-79B0-4C52-955E-F0238AA32437Q38203033-3ED1C7E0-0124-41A1-890D-49041FC7E870Q38388633-7BF92AAE-6B5B-4C09-89CD-DB1B1F034D73Q39213684-8BB3BA0B-45BD-44CA-AE91-C2FF58DE6254Q40372534-DEA35042-56A4-44F7-B2E7-551454DF8D01Q42184918-3A8B083A-0A2D-4154-889A-CB5555E89A11Q42212127-3C4738BD-A10C-4485-87D2-445B2CF49849Q42226125-B0AE7755-E2C6-43A6-96AC-DEB62444C2AAQ42269861-AA1B5FD9-5497-417A-ADB4-F67361663FE4Q42986888-501F56FC-EE0F-4812-873E-FADF19E972CCQ42996604-5E5AE99B-358A-42D3-B948-0119DBC1E468Q46109388-6202A82B-3837-4ED1-B7F5-47724A654EFDQ52300688-192C48E9-3615-45BE-89F6-8A48C7C6A9C3Q54408586-06C5151D-4B63-443B-8585-CF51C7217D75Q57251817-8E516E3D-84B0-4273-82FF-5409D19A4CE9Q74296513-D1812241-1F16-47F8-BFDF-A826A225AB0FQ79416190-98C215DF-8B48-4E54-B175-111BE3F9C7C4Q81362563-B3C448C9-CDA1-4931-A5DA-164225F7BA81Q81679536-DB4F2924-F988-43A9-9355-BB73FEEE0410Q88881101-E6996BCE-EC1C-4CEE-9A7E-09BA9246AA6BQ90135434-F2213981-7CE5-463F-8E8F-FBB4A9286CDF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jan Sperl
@ast
Jan Sperl
@en
Jan Sperl
@es
Jan Sperl
@nl
Jan Sperl
@sl
type
label
Jan Sperl
@ast
Jan Sperl
@en
Jan Sperl
@es
Jan Sperl
@nl
Jan Sperl
@sl
altLabel
Jan Šperl
@en
prefLabel
Jan Sperl
@ast
Jan Sperl
@en
Jan Sperl
@es
Jan Sperl
@nl
Jan Sperl
@sl
P1053
K-1933-2017
P106
P1153
6602711421
P21
P31
P3829
P496
0000-0001-8619-2610